Chronic stress and obesity identified as accelerators of early pancreatic cancer development
A groundbreaking study led by researchers at the University of California, Los Angeles (UCLA) has uncovered a significant link between chronic stress, obesity, and the early progression of pancreatic cancer. The findings provide new insights into how lifestyle factors can influence the onset and severity of one of the most aggressive and deadly forms of cancer.
Understanding the Biological Link Between Stress, Obesity, and Pancreatic Cancer
Through preclinical models, scientists identified a key molecular mechanism that explains how both stress and obesity can trigger changes in pancreatic cells, potentially leading to cancerous growth. The study revealed that stress-related neurotransmitters and obesity-associated hormones activate a protein called CREB, which is closely linked to cancer cell proliferation. Interestingly, these two factors stimulate CREB via distinct biological pathways:
- Stress hormones engage the β-adrenergic receptor/PKA pathway
- Obesity-related hormones predominantly activate the PKD pathway
Despite originating from separate physiological processes, both pathways ultimately contribute to the same oncogenic effect, suggesting that chronic stress and obesity work in tandem to promote pancreatic cancer progression.
Preclinical Findings: Diet, Social Stress, and Cancer Risk
In a series of mouse experiments, researchers found that a high-fat diet alone was sufficient to induce the growth of precancerous pancreatic lesions. However, when combined with social isolation stress, the mice developed significantly more advanced lesions, indicating that stress can compound the harmful effects of an unhealthy diet.
Notably, the study also observed sex-specific differences in how stress influenced cancer progression. Female mice subjected to social isolation exhibited a more pronounced acceleration in cancerous changes compared to their male counterparts. The researchers hypothesise that this disparity could be linked to differences in biological stress responses, particularly the influence of oestrogen and heightened β-adrenergic receptor activity, which may increase susceptibility to stress-induced cancer development.
Potential Clinical Implications and Treatment Strategies
The findings suggest that stress and obesity-driven molecular pathways play a crucial role in accelerating pancreatic cancer onset. This raises the possibility of leveraging existing medications to mitigate these risks. As β-adrenergic receptors appear to be central to stress-induced cancer growth, commonly prescribed beta-blockers—widely used for managing high blood pressure—could be repurposed as a preventive strategy to slow down cancer progression in at-risk individuals.
While further clinical research is needed to confirm these findings in human populations, the study provides compelling evidence that lifestyle factors can significantly influence cancer risk. Interventions targeting stress management, diet modification, and pharmacological prevention may collectively contribute to reducing the incidence of pancreatic cancer.
Publication Details
The study was published in Molecular Cancer Research, offering critical insights into the interplay between stress, obesity, and cancer biology.
Research Team
The study’s first authors are Xiaoying Sun, a postdoctoral researcher in the departments of medicine and surgery at UCLA, and Yaroslav Teper, a project scientist at the David Geffen School of Medicine at UCLA. The senior authors include Dr. Guido Eibl, professor in residence in the department of surgery at UCLA Health, and Dr. Enrique Rozengurt, distinguished professor of medicine and chief of research in the division of digestive diseases at UCLA.
Other contributing authors, all affiliated with UCLA, include James Sinnett-Smith, Mineh Markarian, Dr. Joe Hines, and Dr. Gang Li. Additionally, Eibl, Rozengurt, Hines, and Li are members of the UCLA Health Jonsson Comprehensive Cancer Center.
Funding and Support
The research received funding from several prestigious institutions, including:
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
- Ronald S. Hirshberg Endowed Chair of Pancreatic Cancer Research
- Ronald S. Hirshberg Foundation
These findings highlight the critical need for public awareness and proactive health measures to reduce stress and maintain a healthy lifestyle as potential strategies for cancer prevention.
